Jefferies Group’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$196K Buy
+13,500
New +$196K ﹤0.01% 931
2019
Q4
Sell
-11,250
Closed -$131K 1754
2019
Q3
$131K Buy
+11,250
New +$131K ﹤0.01% 1516